140 related articles for article (PubMed ID: 35829629)
1. Spindle Cell/Sclerosing Rhabdomyosarcoma of the Orbit.
Proia AD
Ophthalmic Plast Reconstr Surg; 2023 Jan-Feb 01; 39(1):e17-e20. PubMed ID: 35829629
[TBL] [Abstract][Full Text] [Related]
2. MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes.
Rekhi B; Upadhyay P; Ramteke MP; Dutt A
Mod Pathol; 2016 Dec; 29(12):1532-1540. PubMed ID: 27562493
[TBL] [Abstract][Full Text] [Related]
3. Hyperostosis in orbital rhabdomyosarcoma.
Rogelio PNA; Ranche FKT; Pe-Yan MR
BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35725289
[TBL] [Abstract][Full Text] [Related]
4. Presentation of orbital rhabdomyosarcoma.
Adhikary HP; Fitzmaurice DJ
Clin Oncol; 1982 Mar; 8(1):21-3. PubMed ID: 7075042
[No Abstract] [Full Text] [Related]
5. Cytomorphology of spindle cell/sclerosing rhabdomyosarcoma, including MYOD1 (LI22R) mutation result.
Rekhi B; Dodd L; Dharavath B; Dutt A
Diagn Cytopathol; 2022 Dec; 50(12):E367-E372. PubMed ID: 35929754
[TBL] [Abstract][Full Text] [Related]
6. Clinical spectrum of primary ophthalmic rhabdomyosarcoma.
Shields CL; Shields JA; Honavar SG; Demirci H
Ophthalmology; 2001 Dec; 108(12):2284-92. PubMed ID: 11733272
[TBL] [Abstract][Full Text] [Related]
7. [Spindle cell/sclerosing rhabdomyosarcoma: a clinicopathological study of 20 cases].
Yang L; Zhang HJ; Yang SJ
Zhonghua Bing Li Xue Za Zhi; 2020 Apr; 49(4):336-342. PubMed ID: 32268670
[No Abstract] [Full Text] [Related]
8. [Evaluation of the results of treatment orbital rhabdomyosarcoma in children].
Chipczyńska B; Grałek M; Hautz W; Kanigowska K; Kocyła-Karczmarewicz B; Trzebicka A; Kepa B
Klin Oczna; 2007; 109(1-3):18-21. PubMed ID: 17687906
[TBL] [Abstract][Full Text] [Related]
9. MYOD1-mutant spindle cell and sclerosing rhabdomyosarcoma: an aggressive subtype irrespective of age. A reappraisal for molecular classification and risk stratification.
Agaram NP; LaQuaglia MP; Alaggio R; Zhang L; Fujisawa Y; Ladanyi M; Wexler LH; Antonescu CR
Mod Pathol; 2019 Jan; 32(1):27-36. PubMed ID: 30181563
[TBL] [Abstract][Full Text] [Related]
10. Spindle Cell/Sclerosing Rhabdomyosarcoma With
Rakheja D; Park JY; Alhasan M; Uddin N
Int J Surg Pathol; 2022 Dec; 30(8):950-955. PubMed ID: 35466752
[TBL] [Abstract][Full Text] [Related]
11. [Neoplastic space-occupying lesions of the orbit. I. Review; hemangioma, lymphangioma and embryonal rhabdomyosarcoma].
Gloor B; Kalman A
Klin Monbl Augenheilkd; 1992 Nov; 201(5):291-301. PubMed ID: 1479785
[TBL] [Abstract][Full Text] [Related]
12. Management of orbital rhabdomyosarcoma in a child with Li-Fraumeni syndrome.
Jivraj I; Somers GR; Belliveau MJ; Malkin D; DeAngelis DD
J AAPOS; 2019 Jun; 23(3):182-185. PubMed ID: 30974170
[TBL] [Abstract][Full Text] [Related]
13. Genomic analysis and preclinical xenograft model development identify potential therapeutic targets for MYOD1-mutant soft-tissue sarcoma of childhood.
Ting MA; Reuther J; Chandramohan R; Voicu H; Gandhi I; Liu M; Cortes-Santiago N; Foster JH; Hicks J; Nuchtern J; Scollon S; Plon SE; Chintagumpala M; Rainusso N; Roy A; Parsons DW
J Pathol; 2021 Sep; 255(1):52-61. PubMed ID: 34086347
[TBL] [Abstract][Full Text] [Related]
14. The expanding morphological and genetic spectrum of MYOD1-mutant spindle cell/sclerosing rhabdomyosarcomas: a clinicopathological and molecular comparison of mutated and non-mutated cases.
Tsai JW; ChangChien YC; Lee JC; Kao YC; Li WS; Liang CW; Liao IC; Chang YM; Wang JC; Tsao CF; Yu SC; Huang HY
Histopathology; 2019 May; 74(6):933-943. PubMed ID: 30604891
[TBL] [Abstract][Full Text] [Related]
15. Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: evidence for a common pathogenesis.
Agaram NP; Chen CL; Zhang L; LaQuaglia MP; Wexler L; Antonescu CR
Genes Chromosomes Cancer; 2014 Sep; 53(9):779-87. PubMed ID: 24824843
[TBL] [Abstract][Full Text] [Related]
16. Multidisciplinary management of adult orbital rhabdomyosarcoma*.
Bagdonaite L; Jeeva I; Chang BY; Kalantzis G; El-Hindy N
Orbit; 2013 Jun; 32(3):208-10. PubMed ID: 23617582
[TBL] [Abstract][Full Text] [Related]
17. Visual outcomes and late complications in paediatric orbital rhabdomyosarcoma.
Eade E; Tumuluri K; Do H; Rowe N; Smith J
Clin Exp Ophthalmol; 2017 Mar; 45(2):168-173. PubMed ID: 27473389
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic and Molecular Study of an Adult Sclerosing Rhabdomyosarcoma of the Extremity:
Gorunova L; Bjerkehagen B; Micci F; Heim S; Panagopoulos I
Cancer Genomics Proteomics; 2020; 17(5):563-569. PubMed ID: 32859634
[TBL] [Abstract][Full Text] [Related]
19. Methylation profiling reveals novel molecular classes of rhabdomyosarcoma.
Clay MR; Patel A; Tran Q; Hedges DJ; Chang TC; Stewart E; Charville G; Cline C; Dyer MA; Orr BA
Sci Rep; 2021 Nov; 11(1):22213. PubMed ID: 34782706
[TBL] [Abstract][Full Text] [Related]
20. [Rhabdomyosarcoma of the orbits in childhood].
Humpl T; Brühl K; Pitz S; de Mooy P; Bartels U; Gutjahr P
Ophthalmologe; 1997 Dec; 94(12):914-9. PubMed ID: 9487763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
